Assignee: The University of Manchester

Location: Manchester, GB
No. of patents: 19

Number	Title	Issue Date
8178578	Chemical compounds A compound of formula (I) is described; wherein the substituents are as defined in the text and wherein the compound is intended for use in the production of a vascular damaging effect in a warm-blooded animal. ...	05/15/2012
8088076	Nervous system monitoring method A method for monitoring the response of a nervous system of a body to a stimulus. The method comprises collecting a set of voltage measurements between selected areas on a surface of the body while current is being passed between selected regions of the surface of t...	01/03/2012
8056732	Microporous polymer material The present invention relates to a microporous material which is a non-network polymer having a chain comprised of repeating units bonded to each other and each including a first generally planar species and a rigid linker, the linker having a point of contortion su...	11/15/2011
7910567	Opticin nucleic acid administration reduces blood vessel formation The invention relates to the use of an agent that promotes class III SLRP activity in the manufacture of a medicament for the inhibition of blood vessel formation. In addition the invention relates to the use of an agent that promotes class III SLRP activity in the ...	03/22/2011
7829555	Drug targeting The invention provides a method of targeting a drug to areas of hypoxic and/or ischemic tissue within the body in which the desired drug species is linked to a non-cytotoxic bioreductive carrier. Also provided by the invention are novel bioreductive conjugates compr...	11/09/2010
7763596	Selective glucocorticoid receptor agonists This invention is directed to a method for treating an inflammatory condition, treating haematological and other malignancies, causing immunosuppression, or preventing or treating transplant rejection in man or other animals which comprises administering to a patien...	07/27/2010
7732485	Treatment of cancer The invention relates to the treatment of cancers, in particular, cancers that are resistant to platinum based chemotherapeutic agents. A pharmaceutical composition for the treatment of cancer comprising an effective amount of a compound having two gold(I) atoms eac...	06/08/2010
7723056	Particles Lipid vesicle particles capable of being targeted to a cell type of interest, said particle incorporating a peptide which is responsive to a predetermined metabolic signal from the targeted cell so as to modulate the permeability of the particle, said particle furth...	05/25/2010
7690514	Microporous polymer material A microporous material comprises organic macromolecules comprised of first generally planar species connected by rigid linkers having a point of contortion such that two adjacent first planar species connected by the linker are held in non-coplanar orientation, subj...	04/06/2010
7598323	Resin cross-linking A method of effecting cross-linking of a resin comprises generating vinyl sulfonyl moieties in situ with the resin, said sulfonyl moieties then undergoing a reaction which effects cross-linking of the resin. The vinyl sulfonyl moieties may be generated as a result o...	10/06/2009
7553815	Therapeutic use A method of chemoprevention of the onset of invasive breast cancer in a high risk patient comprises administering to the patient an effective amount of an EGFR tyrosine kinase inhibitor. ...	06/30/2009
7499377	Pressure wave piezoelectric sensor A sensing device and method. The device includes a first element and a second element. Each of the elements includes a first electrode, and a second electrode, and a piezoelectric layer between and connected to the first and second electrode. The first electrode, se...	03/03/2009
7457787	Neural network component A neural network component includes a plurality of inputs, at least one processing element, at least one output, and a digital memory storing values at addresses respectively corresponding to the at least one processing element, wherein the at least one processing e...	11/25/2008
7358224	Class III SLRP agonists for the reduction of blood vessel formation The invention relates to the use of an agent that promotes class III SLRP activity in the manufacture of a medicament for the inhibition of blood vessel formation. In addition the invention relates to the use of an agent that promotes class III SLRP activity in the ...	04/15/2008
7351552	Modified pro-α peptides and their uses A modified pro-α chain comprising a triple helix forming domain linked to a polypeptide from at least part of a laminin glycoprotein. The pro-α chain may form part of a procollagen molecule that has the N-terminal domain retained. The procollagen molecules may be ...	04/01/2008
7224026	Nanoelectronic devices and circuits Diode devices with superior and pre-settable characteristics and of nanometric dimensions, comprise etched insulative lines (8, 16, 18) in a conductive substrate to define between the lines charge carrier flow paths, formed as elongate channels (20) at...	05/29/2007
7043329	Pressure garment There is disclosed a method for making a pressure garment, comprising the steps of: defining 3D shape and pressure profile characteristics of a garment; specifying a knitting pattern for the garment;	05/09/2006
7020940	Texturing yarn There is disclosed a method of texturing yarn products wherein the yarn product is passed along a predetermined yarn path through a liquid jet device applying a force to the yarn transversely to the axis thereof, comprising directing the liquid as it passes through ...	04/04/2006
6876755	Face sub-space determination A method of determining face sub-spaces includes making initial estimates of the sub-spaces, for example lighting, pose, identity and expression, using Principle Component Analysis on appropriate groups of faces. An iterative algorithm is applied to image codings to...	04/05/2005

PatentStorm

Bizarre Patents

PatentStorm News

Assignee: The University of Manchester